Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 243

1.

Treating anxiety after stroke (TASK): the feasibility phase of a novel web-enabled randomised controlled trial.

Chun HY, Carson AJ, Dennis MS, Mead GE, Whiteley WN.

Pilot Feasibility Stud. 2018 Aug 14;4:139. doi: 10.1186/s40814-018-0329-x. eCollection 2018.

2.
3.

Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.

Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, Finn MB, Hoyle R, Keyser J, Lefton KB, Robinson GO, Serrano JR, Silverman AP, Guo JL, Getz J, Henne K, Leyns CE, Gallardo G, Ulrich JD, Sullivan PM, Lerner EP, Hudry E, Sweeney ZK, Dennis MS, Hyman BT, Watts RJ, Holtzman DM.

J Clin Invest. 2018 May 1;128(5):2144-2155. doi: 10.1172/JCI96429. Epub 2018 Mar 30.

4.

Long-Term Morphological Changes of Symptomatic Lacunar Infarcts and Surrounding White Matter on Structural Magnetic Resonance Imaging.

Loos CMJ, Makin SDJ, Staals J, Dennis MS, van Oostenbrugge RJ, Wardlaw JM.

Stroke. 2018 May;49(5):1183-1188. doi: 10.1161/STROKEAHA.117.020495. Epub 2018 Mar 22.

5.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.

Al-Shahi Salman R, Dennis MS, Murray GD, Innes K, Drever J, Dinsmore L, Williams C, White PM, Whiteley WN, Sandercock PAG, Sudlow CLM, Newby DE, Sprigg N, Werring DJ; RESTART collaborators.

Trials. 2018 Mar 5;19(1):162. doi: 10.1186/s13063-018-2542-6.

6.

Anxiety After Stroke: The Importance of Subtyping.

Chun HY, Whiteley WN, Dennis MS, Mead GE, Carson AJ.

Stroke. 2018 Mar;49(3):556-564. doi: 10.1161/STROKEAHA.117.020078. Epub 2018 Feb 6.

7.

Relative Target Affinities of T-Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model.

Mandikian D, Takahashi N, Lo AA, Li J, Eastham-Anderson J, Slaga D, Ho J, Hristopoulos M, Clark R, Totpal K, Lin K, Joseph SB, Dennis MS, Prabhu S, Junttila TT, Boswell CA.

Mol Cancer Ther. 2018 Apr;17(4):776-785. doi: 10.1158/1535-7163.MCT-17-0657. Epub 2018 Jan 16.

PMID:
29339550
8.

An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast Cancer.

Bhakta S, Crocker LM, Chen Y, Hazen M, Schutten MM, Li D, Kuijl C, Ohri R, Zhong F, Poon KA, Go MAT, Cheng E, Piskol R, Firestein R, Fourie-O'Donohue A, Kozak KR, Raab H, Hongo JA, Sampath D, Dennis MS, Scheller RH, Polakis P, Junutula JR.

Mol Cancer Ther. 2018 Mar;17(3):638-649. doi: 10.1158/1535-7163.MCT-17-0813. Epub 2017 Dec 27.

9.
10.

The relation between total cerebral small vessel disease burden and gait impairment in patients with minor stroke.

Loos CM, McHutchison C, Cvoro V, Makin SD, Staals J, Chappell F, Dennis MS, van Oostenbrugge RJ, Wardlaw JM.

Int J Stroke. 2018 Jul;13(5):518-524. doi: 10.1177/1747493017730780. Epub 2017 Sep 14.

PMID:
28906203
11.

Small Vessel Disease and Dietary Salt Intake: Cross-Sectional Study and Systematic Review.

Makin SDJ, Mubki GF, Doubal FN, Shuler K, Staals J, Dennis MS, Wardlaw JM.

J Stroke Cerebrovasc Dis. 2017 Dec;26(12):3020-3028. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.004. Epub 2017 Sep 8. Review.

12.

White matter hyperintensity reduction and outcomes after minor stroke.

Wardlaw JM, Chappell FM, Valdés Hernández MDC, Makin SDJ, Staals J, Shuler K, Thrippleton MJ, Armitage PA, Muñoz-Maniega S, Heye AK, Sakka E, Dennis MS.

Neurology. 2017 Sep 5;89(10):1003-1010. doi: 10.1212/WNL.0000000000004328. Epub 2017 Aug 9.

13.

The nature, characteristics and associations of care home staff stress and wellbeing: a national survey.

Islam MS, Baker C, Huxley P, Russell IT, Dennis MS.

BMC Nurs. 2017 May 8;16:22. doi: 10.1186/s12912-017-0216-4. eCollection 2017.

14.

Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study.

Chappell FM, Del Carmen Valdés Hernández M, Makin SD, Shuler K, Sakka E, Dennis MS, Armitage PA, Muñoz Maniega S, Wardlaw JM.

Trials. 2017 Feb 21;18(1):78. doi: 10.1186/s13063-017-1825-7.

15.

Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice.

Lo M, Kim HS, Tong RK, Bainbridge TW, Vernes JM, Zhang Y, Lin YL, Chung S, Dennis MS, Zuchero YJ, Watts RJ, Couch JA, Meng YG, Atwal JK, Brezski RJ, Spiess C, Ernst JA.

J Biol Chem. 2017 Mar 3;292(9):3900-3908. doi: 10.1074/jbc.M116.767749. Epub 2017 Jan 11.

16.

An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia.

Leong SR, Sukumaran S, Hristopoulos M, Totpal K, Stainton S, Lu E, Wong A, Tam L, Newman R, Vuillemenot BR, Ellerman D, Gu C, Mathieu M, Dennis MS, Nguyen A, Zheng B, Zhang C, Lee G, Chu YW, Prell RA, Lin K, Laing ST, Polson AG.

Blood. 2017 Feb 2;129(5):609-618. doi: 10.1182/blood-2016-08-735365. Epub 2016 Dec 1.

17.

Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study.

John A, Marchant AL, Fone DL, McGregor JI, Dennis MS, Tan JO, Lloyd K.

Psychol Med. 2016 Dec;46(16):3315-3327.

18.

Cognitive Outcomes following Thrombolysis in Acute Ischemic Stroke: A Systematic Review.

Broome LJ, Battle CE, Lawrence M, Evans PA, Dennis MS.

J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2868-2875. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.048. Epub 2016 Aug 25. Review.

PMID:
27569709
19.

Newspaper Reporting on a Cluster of Suicides in the UK.

John A, Hawton K, Gunnell D, Lloyd K, Scourfield J, Jones PA, Luce A, Marchant A, Platt S, Price S, Dennis MS.

Crisis. 2017 Jan;38(1):17-25. doi: 10.1027/0227-5910/a000410. Epub 2016 Jul 22.

PMID:
27445013
20.

Author Response.

Wardlaw JM, Brazzelli M, Chappell F, Dennis MS, Sandercock PA.

Neurology. 2016 Feb 16;86(7):697. No abstract available.

PMID:
27303783

Supplemental Content

Loading ...
Support Center